Skip to content

Herbal Formulation and Amlodipine in Essential Hypertension

Comparative Evaluation of a Herbal Formulation and Amlodipine in Essential hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045143
Enrollment
40
Registered
2022-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

GURUKUL CAMPUS UAU HARDWAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing to participate in the study. 2)Patients of either sex with age between 18-70 years. 3)Patients having Hypertension between time interval of 6 months to 1 year. 4)Patients suffering from stage 1 Hypertension (SBP140-159mmHg, DBP 90-99mmHg) 5)Patients suffering from Isolated Systolic Hypertension.

Exclusion criteria

Exclusion criteria: 1)Patients not willing to participate in the study. 2)Patients of either sex below 18 years & above 70 years will be excluded from the study. 3)Patients having Hypertension for 1 year will be excluded. 4)Patients of stage 2 Hypertension (SBP >160mmHg and DBP >100mmHg) 5)Patients suffering from serious comorbidities like Renal failure, Coronary Artery Disease, taking medication/drug (oral contraceptives, steroids, chronic use of NSAIDs etc�) 6)Alcoholic and/or drug abusers. 7)History of hypersensitivity to the trail drugs or any of its ingredients. 8)Pregnant /lactating woman. 9)Patients who have completed participation in any other clinical trail during the past 6 months.

Design outcomes

Primary

MeasureTime frame
Relief in subjective parameters like- a)Headache (Shiro ruja) b)Giddiness (Bhrama) c)Palpitations (hriddrava) d)Breathlessness (shwasa) Timepoint: At 1st day,10th day,20th day, and 30th day

Secondary

MeasureTime frame
The objective assessment will be done on the basis of changes in clinical findings & laboratory parameters. 1)Urine 2)CBC 3)RBS 4)Serum creatinine 5)Lipid profile 6)ECG Timepoint: At 1st day and 30th day

Countries

India

Contacts

Public ContactDr Arun Kumar Tripathi

Gurukul campus UAU Haridwar

draruntripathi@yahoo.com9415720013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026